Axis Midcap mutual fund review: Worthy pick over market cycles


ET Wealth collaborates with Value Research to analyse top mutual funds. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.

BASIC FACTS

DATE OF LAUNCH

18 FEBRUARY 2011

CATEGORY

EQUITY

TYPE

MID CAP

AUM*

Rs.17,645 crore

BENCHMARK


S&P BSE 150 MIDCAP

TOTAL RETURN INDEX

image-2

WHAT IT COSTS

NAV**

GROWTH OPTION

Rs.64.32

IDCW

Rs.31.41

MINIMUM INVESTMENT

Rs.5,000

image-3

MINIMUM SIP AMOUNT

Rs.500

EXPENSE RATIO*** (%)

1.63

EXIT LOAD

For units in excess of 10% of the investment,1% will be charged for redemption within 365 days

*AS ON 31 MARCH 2022
**AS ON 4 MAY 2022
***AS ON 31 MARCH 2022

FUND MANAGER

SHREYASH DEVALKAR

TENURE: 5 YEARS, 5 MONTHS

image-4

image-5

Recent portfolio changes
New Entrants


Gujarat Fluorochemicals, TVS Motor Company, Vedant Fashions, Fortis Healthcare, Linde India, Oberoi Realty.


Complete Exits


Tata Consumer Products, FSN E-Commerce Ventures, Indiamart Intermesh, Indigo Paints, Medplus Health Services.

image-6

Should you buy?

This mid-cap fund retains a heavy presence in large-caps unlike many peers. This is owing to the strict emphasis on quality in the fund manager’s stock selection approach. His preference is for businesses that either have leadership position within a niche area or challenge bigger rivals in a larger arena. The portfolio size has expanded from 35-40 stocks two years ago to around 60 as more businesses started participating in the earnings uptick amid economic recovery. Owing to its distinct style, the fund boasts a much superior downside performance but does tend to underperform in momentum driven markets like in 2021. It remains a worthy pick over complete market cycles.

(Source: Valueresearch)



Source link